U-EPX levels and wheezing in infants and young children with and without RSV bronchiolitis

Respiratory Medicine

Volumn 100, Issue 5, 2006, Pages 878-883

  Kristjánsson, Sigurdur ^a   Wennergren, David ^b   Eriksson, Björn ^b   Thórarinsdóttir, Halldóra ^a   Wennergren, Göran ^c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Asthma; Bronchiolitis; EPX; Infant; Respiratory syncytial virus; Wheezing

Indexed keywords

CREATININE; EOSINOPHIL PROTEIN X;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL CARE; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STATISTICAL SIGNIFICANCE; VIRAL BRONCHIOLITIS; WHEEZING;

BIOLOGICAL MARKERS; BRONCHIOLITIS; CHILD, PRESCHOOL; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 33645880414     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.08.013     Document Type: Article

References (13)

1. Wennergren G., and Kristjánsson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 18 (2001) 1044-1058
2. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (1999) 541-545
3. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171 (2005) 137-141
4. Kristjánsson S., Strannegård I.-L., Strannegård O., Peterson C., Enander I., and Wennergren G. Urinary eosinophil protein X (EPX) in children with atopic asthma. A useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 97 (1996) 1179-1187
5. Wennergren G. Inflammatory mediators in blood and urine. Paediatr Respir Rev 1 (2000) 259-265
6. Venge P. Monitoring the allergic inflammation. Allergy 59 (2004) 26-32
7. Wolthers O.D. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 14 (2003) 248-254
8. Dimova-Yaneva D., Russell D., Main M., Brooker R.J., and Helms P.J. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 34 (2004) 555-558
9. Storm van's Gravesande K., Mattes J., Gruntjens T., Kopp M., Seydewitz H.H., Moseler M., et al. Circadian variation of urinary eosinophil protein X in asthmatic and healthy children. Clin Exp Allergy 29 (1999) 1497-1501
10. Koller D.Y., Wojnarowski C., Herkner K.R., Weinlander G., Raderer M., Eichler I., et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 99 (1997) 752-756
11. Reijonen T.M., Korppi M., Kuikka L., Savolainen K., Kleemola M., Mononen I., et al. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis. Pediatr Pulmonol 23 (1997) 397-403
12. Ehlenfield D.R., Cameron K., and Welliver R.C. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 105 (2000) 79-83
13. Øymar K., Havnen J., Halvorsen T., and Bjerknes R. Eosinophil counts and urinary eosinophil protein X in children hospitalized for wheezing during the first year of life: prediction of recurrent wheezing. Acta Paediatr 90 (2001) 843-849